10X Genomics hold rating reiterated by TD Cowen By Investing.com
TD Cowen maintained a Hold rating on 10X Genomics (NASDAQ:TXG) with a firm price target of $20.00. The decision came after 10X Genomics revealed plans at an industry event to introduce new single-cell (SC) products in the fourth quarter.…